IRIS
GASTALDI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.359
AS - Asia 973
EU - Europa 820
SA - Sud America 150
AF - Africa 56
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.361
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.297
SG - Singapore 330
CN - Cina 247
IT - Italia 185
VN - Vietnam 124
DE - Germania 120
RU - Federazione Russa 119
IE - Irlanda 113
BR - Brasile 111
HK - Hong Kong 109
FI - Finlandia 69
GB - Regno Unito 55
FR - Francia 52
IN - India 45
BD - Bangladesh 32
CA - Canada 32
ZA - Sudafrica 31
ES - Italia 24
MX - Messico 20
JP - Giappone 16
SE - Svezia 14
AR - Argentina 12
BE - Belgio 11
PL - Polonia 11
CO - Colombia 10
MA - Marocco 10
NL - Olanda 10
AT - Austria 9
IQ - Iraq 8
TR - Turchia 8
CZ - Repubblica Ceca 7
ID - Indonesia 7
MY - Malesia 6
EC - Ecuador 5
LT - Lituania 5
NP - Nepal 5
PK - Pakistan 5
SA - Arabia Saudita 5
BO - Bolivia 4
GR - Grecia 4
KE - Kenya 4
PH - Filippine 4
ET - Etiopia 3
IL - Israele 3
KG - Kirghizistan 3
PY - Paraguay 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EG - Egitto 2
HN - Honduras 2
JO - Giordania 2
NI - Nicaragua 2
UA - Ucraina 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
GD - Grenada 1
GT - Guatemala 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
Totale 3.361
Salva come PNG Salva come JPEG
Città #
Singapore 197
San Jose 176
Ashburn 153
Dublin 113
Chandler 110
Hong Kong 106
Council Bluffs 96
Dallas 94
Los Angeles 64
Munich 64
Beijing 55
Ho Chi Minh City 50
Helsinki 47
New York 44
Boardman 43
Lauterbourg 35
Milan 32
Hanoi 27
Johannesburg 27
Buffalo 26
Pavia 22
Moscow 20
Redondo Beach 20
São Paulo 20
Turku 20
London 15
Orem 15
Rome 15
Tokyo 15
Montreal 14
Shanghai 14
Lawrence 13
Nanjing 13
Princeton 13
Wilmington 13
Frankfurt am Main 12
Brooklyn 11
Brussels 11
Medford 11
Stockholm 11
Ann Arbor 9
Mexico City 9
Pune 9
Santa Clara 9
Chicago 8
Madrid 8
San Francisco 8
Warsaw 8
Atlanta 7
Changsha 7
Chennai 7
Manchester 7
Medellín 7
Nuremberg 7
Poplar 7
Bologna 6
Brno 6
Da Nang 6
Düsseldorf 6
Florence 6
Baghdad 5
Cagliari 5
Guangzhou 5
Houston 5
Paris 5
Rio de Janeiro 5
Seattle 5
Amsterdam 4
Cambridge 4
Casablanca 4
Denver 4
Dhaka 4
Falkenstein 4
Fortaleza 4
Hebei 4
Hyderabad 4
Jacksonville 4
Nanchang 4
New Delhi 4
North Kansas City 4
Querétaro 4
Shenyang 4
The Dalles 4
Toronto 4
Athens 3
Berlin 3
Bishkek 3
Biên Hòa 3
Boston 3
Calgary 3
Castelfranco Emilia 3
City of London 3
Curitiba 3
Franca 3
Genoa 3
Hangzhou 3
Kathmandu 3
Mumbai 3
Nairobi 3
Padua 3
Totale 2.155
Salva come PNG Salva come JPEG
Nome #
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 161
Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma 142
Predictors of outcome in a large retrospective cohort of patients with transverse myelitis 130
COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature 130
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 129
Diagnostics of dysimmune peripheral neuropathies 121
Retrograde Amnesia in LGI1 and CASPR2 Limbic Encephalitis: Two Case Reports and a Systematic Literature Review 115
Diagnostics of anti-MAG antibody polyneuropathy 115
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 113
Antibodies to neuronal surface antigens in patients with a clinical diagnosis of neurodegenerative disorder 108
Letter to Editor 106
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis 104
Lower motor neuron syndrome in a patient with HER2-positive metastatic breast cancer: A case report and review of the literature 98
Autoantibodies against neuroglial surface antigens: laboratory strategies for their detection and roles in acquired demyelinating syndromes, autoimmune encephalitis and acquired neuromyotonia 94
MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment 94
Primary central nervous system lymphoma mimicking autoimmune encephalitis: the role of autoantibody testing 90
Beyond Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies: Alternative Causes of Optic Neuritis 88
Seronegative autoimmune diseases: A challenging diagnosis 87
AQP4 autoantibodies in patients with idiopathic normal pressure hydrocephalus 85
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders 84
Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis 81
General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis 80
HaNDL syndrome: a reversible cerebral vasoconstriction triggered by an infection? A case report and a case-based review 80
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors 79
Visual System Involvement in Glial Fibrillary Acidic Protein Astrocytopathy 75
Movement disorders associated with neuronal antibodies: a data-driven approach 75
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study 71
Neurofilament-light chain quantification by Simoa and Ella in plasma from patients with dementia: a comparative study 66
Towards a standardised analysis of CSF in inflammatory neuropathies 61
Improving laboratory diagnostics in myasthenia gravis 59
COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up 57
Paraneoplastic Neurological Syndromes: Transitioning Between the Old and the New 53
Neurological complications due to copper deficiency in the context of Wilson disease treatment: a case report with long-term follow-up and review of the literature 53
Exposome, oxidative stress and inflammation in persons with multiple sclerosis: the EXPOSITION study protocol 51
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 45
Unravelling the Acute, Chronic and Steroid-Refractory Management of High-Grade Neurological Immune-Related Adverse Events: A Call to Action 44
Insights from the EXPOSITION Study: Exposome-related microRNA Expression and Clinical Outcomes in People with multiple sclerosis 37
Clustering of Exposome and Lifestyle Data to Support Differential Expression Analysis of Circulating miRNAs in Multiple Sclerosis 35
Applying the Supporting Features for MOGAD Diagnosis to Patients With Multiple Sclerosis 29
Adoptive JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy: Experience from Two Italian Centers 21
Biomarkers Identifying Tendency to Suicide (BITS): detection of biomarkers in adolescents with suicidal ideation or suicidal behavior for early prevention or intervention. A prospective cohort study 20
Two-year OCT follow-up in multiple sclerosis patients on Ofatumumab shows retinal preservation over non-antiCD20 treatments 14
Diagnostic Value of the “Insular Knife‐Cut” Sign in Patients With Suspected Herpes Simplex Virus Encephalitis 9
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies 7
Validation of the MOG-AR Score 7
The supporting role of Visual Evoked Potentials for the diagnosis of Optic Neuritis within the 2022 ICON criteria 6
Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis 6
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 2
Totale 3.417
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.208
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/202265 3 1 1 1 1 1 2 4 5 0 11 35
2022/2023310 26 25 5 33 26 27 0 12 133 7 14 2
2023/2024223 24 25 3 10 11 66 6 29 0 7 8 34
2024/2025732 44 40 35 20 18 52 38 16 179 47 75 168
2025/20262.006 119 88 151 258 241 105 277 87 211 131 260 78
Totale 3.417